Induction of tolerance by oral administration of beta-tubulin in an animal model of autoimmune inner ear disease

ORL

Volumn 71, Issue 3, 2009, Pages 135-141

  Cai, Qing ^a,b   Du, Xiaoping ^a   Zhou, Bin ^a   Cai, Chun ^a   Kermany, Mohammad Habiby ^a   Yoo, Taijune ^a,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c NONE   (United States)

Author keywords

Tubulin; Autoimmune inner ear disease, mice; Oral tolerance

Indexed keywords

BETA TUBULIN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUDITORY THRESHOLD; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; FEMALE; HEARING LOSS; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INNER EAR DISEASE; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL; TH3 CELL;

ADMINISTRATION, ORAL; ANIMALS; AUTOIMMUNE DISEASES; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EAR, INNER; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HEARING LOSS; IMMUNE TOLERANCE; IMMUNIZATION; LABYRINTH DISEASES; LYMPHOCYTES; MICE; MICE, INBRED C57BL; SPLEEN; TUBULIN;

EID: 64149097770     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000212116     Document Type: Article

References (37)

1. Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM: Tumor necrosis factor-α, an initiator, and etanercept, an inhibitor of cochlear inflammation. Laryngoscope 2002; 112: 1627-1634. (Pubitemid 34977568)
2. Harris JP, Ryan AF: Fundamental immune mechanisms of the brain and inner ear. Otolaryngol Head Neck Surg 1995; 112: 639-653.
3. Ryan AF, Keithley EM, Harris JP: Autoimmune inner ear disorders. Curr Opin Neurol 2001; 14: 35-40.
4. Yoo TJ, Stuart JM, Kang AH, Townes AS, Tomoda K, Dixit S: Type II collagen autoimmunity in otosclerosis and Ménière's disease. Science 1982; 217: 1153-1155. (Pubitemid 12069036)
5. Suzuki M, Yazawa Y, Yoo TJ, Cheng KC, Krug MS, Bernstein J: Antibodies against inner ear proteins in the sera of patients with inner ear disease. ORL 1997; 59: 10-17. (Pubitemid 27129944)
6. Yoo TJ, Tanaka H, Kwon SS, Krug M, Yazawa Y, Suzuki M, Kitajima K: β-Tubulin as an autoantigen for autoimmune inner ear disease; in Sterkers O, Ferrary E, Dauman R, Sauvage JP, Tran Bahuy P (eds): Ménière's Disease. The Hague, Kugler, 2000, pp 529-535.
7. Du X, Yoo TJ, Mora R: Distribution of betatubulin in the guinea pig inner ear. ORL 2003; 65: 7-16. (Pubitemid 36302447)
8. Yoo TJ, Shea J Jr, Ge X, Kwon SS, Yazawa Y, Sener O, Mora F, Mora R, Mora M, Barbieri M, Du X: Presence of autoantibodies in the sera of Ménière's disease. Ann Otol Rhinol Laryngol 2001; 110: 425-429. (Pubitemid 32433853)
9. Suzuki M, Krug MS, Cheng KC, Yazawa Y, Bernstein J, Yoo TJ: Antibodies against inner ear proteins in the sera of patients with inner ear disease. ORL J Otorhinolaryngol Relat Spec 1997; 59: 10-17. (Pubitemid 27129944)
10. Teitelbaum D, Arnon R, Sela M: Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1. Proc Natl Acad Sci USA 1999; 96: 3842-3848. (Pubitemid 29168998)
11. Maron R, Slavin AJ, Hoffmann E, Komagata Y: Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines. Int Immunol 2002; 14: 131-138. (Pubitemid 34144737)
12. Benson JM, Stuckman SS, Cox KL: Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis. J Immunol 1999; 162: 6247-6254.
13. Trune DR, Kempton JB: Female MRL.MpJFaslpr autoimmune mice have greater hearing loss than males. Hear Res 2002; 167: 170-174.
14. Gonnella PA, Kodali D, Weiner HL: Induction of low dose oral tolerance in monocyte chemoattractant protein-1- and CCR2-deficient mice. J Immunol 2003; 170: 2316-2322. (Pubitemid 36245617)
15. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL: Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991; 88: 10252-10258. (Pubitemid 21915813)
16. Kim N, Cheng KC, Kwon SS, Mora R, Barbieri M, Yoo TJ: Oral administration of collagen conjugated with cholera toxin induces tolerance to type II collagen and suppresses chondritis in an animal model of autoimmune ear disease. Ann Otol Rhinol Laryngol 2001; 110: 646-654. (Pubitemid 32634903)
17. Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke GJ: Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 1986; 83: 7443-7446. (Pubitemid 16000538)
18. Thompson HS, Staines NA: Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 1986; 64: 581-586.
19. Chen Y, Inobe J, Weiner HL: Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J Immunol 1995; 155: 910-916.
20. Nagatani K, Dohi M, To Y, Tanaka R, Okunishi K, Nakagome K, Sagawa K, Tanno Y, Komagata Y, Yamamoto K: Splenic dendritic cells induced by oral antigen administration are important for the transfer of oral tolerance in an experimental model of asthma. J Immunol 2006; 176: 1481-1489. (Pubitemid 43134291)
21. Ke Y, Kapp JA: Oral antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells. J Immunol 1996; 156: 916-921.
22. Chen Y, Inobe J, Weiner HL: Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J Immunol 1995; 155: 910-916.
23. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGF-β following antigen specific triggering. Proc Natl Acad Sci USA 1992; 89: 421-425.
24. Chen Y, Inobe J, Weiner HL: Inductive events in oral tolerance in the TCR transgenic adoptive transfer model. Cell Immunol 1997; 178: 62-68. (Pubitemid 27250280)
25. Marth T, Strober W, Kelsall BL: High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J Immunol 1996; 157: 2348-2357. (Pubitemid 126450444)
26. Spiekermann GM, Nagler-Anderson C: Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue. J Immunol 1998; 161: 5825-5831.
27. Chen Y, Kuchroo VK, Inobe JI, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237-1240. (Pubitemid 24291983)
28. Melamed D, Friedman A: Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 1993; 23: 935-942. (Pubitemid 23101082)
29. Smith KM, Eaton AD, Finlayson LM, Garside P: Oral tolerance. Am J Respir Crit Care Med 2000; 162: 175-178.
30. Faria AM, Weiner HL: Oral tolerance: mechanism and therapeutic applications. Adv Immunol 1999; 73: 153-264. (Pubitemid 29300430)
31. Weiner HL: Induction and mechanism of action of transforming growth factor-β secreting Th3 regulatory cells. Immunol Rev 2001; 182: 207-214. (Pubitemid 33070220)
32. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM: Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 1991; 147: 2155-2163.
33. Friedman A, Weiner HL: Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 1994; 91: 6688-6692. (Pubitemid 24200727)
34. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vivo and in vitro immune response by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA 1992; 89: 421-425.
35. Chen Y, Inobe JI, Marks R, Gonnella P, Kuchroo VK, Weiner HL: Peripheral deletion of antigen-reactive T cells following oral tolerance. Nature 1995; 376: 177-180.
36. Pawankar R, Tomiyama S, Ikezono T, Nonaka M, Jinnouchi K, Yagi T: Interferon-gamma expression in the inner ear of rats following secondary immune reaction in the endolymphatic sac. Acta Otolaryngol Suppl 2004; 553:6-12. (Pubitemid 39093369)
37. Tomiyama S: Th1: mediator lymphocytes in experimental autoimmune labyrinthitis. Acta Otolaryngol 2001; 121: 673-678.